Since it is temporarily unknown by which molecular mechanism baicalein regulates cancer cells, this study determined GC cell viability following treatment with various concentrations of baicalein, and the results unraveled that baicalein impeded the PI3K/AKT pathway, activated ERS, reduced cell viability, and facilitated apoptosis in a dose-dependent pattern. This evidence concerns the gene AKT1 and cancer.